Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study.

INTRODUCTION The benefit of partial nephrectomy (PN) compared to radical nephrectomy (RN) for T1a renal cell carcinoma (RCC) remains uncertain, with observational studies conflicting with level 1 evidence. Therefore, the purpose of this population-based study was to compare long-term outcomes in patients undergoing PN or RN for T1a RCC. METHODS We studied 5670 patients in Ontario, Canada undergoing PN or RN for T1a RCC. The primary outcome was overall survival (OS). Secondary outcomes were cancer-specific survival (CSS), chronic kidney disease (CKD), end-stage renal disease (ESRD), and myocardial infarction (MI). We used multivariable Cox proportional hazard models to evaluate the association between PN or RN and these outcomes. A sensitivity analysis was performed in patients with a preoperative serum creatinine available. RESULTS Median followup was 77 months. Compared to RN, PN was associated with significantly improved OS (hazard ratio [HR] 0.73; 95% confidence interval [CI] 0.63-0.84), reduced risk of CKD (HR 0.18; 95% CI 0.12-0.27) and improved CSS (HR 0.45; 95% CI 0.30-0.65). The risk of myocardial infarction was not significantly different between groups (HR 0.91; 95% CI 0.62-1.34). Few patients (n=15) required renal replacement therapy. In the sensitivity analysis, the association between type of surgery and OS and CKD persisted, while the association with CSS did not. CONCLUSIONS Our study found that in patients undergoing surgery for T1a RCC, PN was associated with improved OS and reduced risk of CKD compared to RN. However, few patients in either group developed ESRD requiring renal replacement therapy.

[1]  Lorenzo Marconi,et al.  European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. , 2019, European urology.

[2]  D. Parekh,et al.  A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry. , 2018, Urologic oncology.

[3]  Jeffrey A. Cadeddu,et al.  Adult Urology Oncology : Adrenal / Renal / Upper Tract / Bladder lized Renal Cancer : AUA Guideline , 2017 .

[4]  Chad A. LaGrange,et al.  Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  Xunbo Jin,et al.  Partial nephrectomy vs. radical nephrectomy for renal tumors: A meta-analysis of renal function and cardiovascular outcomes. , 2016, Urologic oncology.

[6]  P. Austin,et al.  Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study. , 2016, Pharmacological research.

[7]  E. Bass,et al.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis. , 2016, The Journal of urology.

[8]  F. Keeley,et al.  Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit , 2016, BJU international.

[9]  I. Derweesh,et al.  Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate. , 2015, European urology.

[10]  Ariana Znaor,et al.  International variations and trends in renal cell carcinoma incidence and mortality. , 2015, European urology.

[11]  E. Messing,et al.  Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. , 2014, European urology.

[12]  R. Thompson,et al.  Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis. , 2012, The Journal of urology.

[13]  R. Sylvester,et al.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2011, European urology.

[14]  S. Cole,et al.  Competing risk regression models for epidemiologic data. , 2009, American journal of epidemiology.

[15]  Peter C. Austin,et al.  Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research , 2009, Commun. Stat. Simul. Comput..

[16]  R. Sylvester,et al.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2007, European urology.

[17]  Jeff Scott Renal Cell , 2020, Definitions.

[18]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[19]  V. Janout,et al.  Epidemiology and risk factors of kidney cancer. , 2004, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[20]  H. Welch,et al.  Are deaths within 1 month of cancer-directed surgery attributed to cancer? , 2002, Journal of the National Cancer Institute.

[21]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .